W

WuXi XDC Cayman Inc
HKEX:2268

Watchlist Manager
WuXi XDC Cayman Inc
HKEX:2268
Watchlist
Price: 16.7 HKD -1.53% Market Closed
Updated: May 20, 2024

WuXi XDC Cayman Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

WuXi XDC Cayman Inc
Operating Income Peer Comparison

Comparables:
603259
300759
2269
300347
1548

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
W
WuXi XDC Cayman Inc
HKEX:2268
Operating Income
¥147.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Operating Income
¥10.9B
CAGR 3-Years
43%
CAGR 5-Years
40%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Operating Income
¥1.7B
CAGR 3-Years
11%
CAGR 5-Years
29%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Operating Income
¥4.1B
CAGR 3-Years
36%
CAGR 5-Years
43%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Operating Income
¥1.6B
CAGR 3-Years
19%
CAGR 5-Years
25%
CAGR 10-Years
32%
Genscript Biotech Corp
HKEX:1548
Operating Income
-$387.4m
CAGR 3-Years
-23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is WuXi XDC Cayman Inc's Operating Income?
Operating Income
147.8m CNY

Based on the financial report for Dec 31, 2022, WuXi XDC Cayman Inc's Operating Income amounts to 147.8m CNY.

What is WuXi XDC Cayman Inc's Operating Income growth rate?
Operating Income CAGR 1Y
116%

Over the last year, the Operating Income growth was 116%.